IL15-DC Vaccine in Patients With High Risk Melanoma - Exploratory Phase I/II Trial
Phase of Trial: Phase I/II
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Dendritic cell vaccines (Primary) ; Interleukin-15 (Primary) ; Cancer vaccines; Granulocyte colony-stimulating factors; Keyhole limpet haemocyanin
- Indications Malignant melanoma
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 20 Dec 2016 Status changed from active, no longer recruiting to completed.
- 13 Jan 2016 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.